Загрузка...
The Systemic Immune Network in Recent Onset Type 1 Diabetes: Central Role of Interleukin-1 Receptor Antagonist (DIATOR Trial)
BACKGROUND: The hypothesis was tested that the systemic immune milieu in recent-onset type 1 diabetes is associated with residual beta cell function and other metabolic patient characteristics. METHODS AND FINDINGS: All patients (n = 89, 40% female) of the Diabetes and Atorvastatin (DIATOR) Trial we...
Сохранить в:
Главные авторы: | , , , , , , , |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
Public Library of Science
2013
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3753272/ https://ncbi.nlm.nih.gov/pubmed/23991111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0072440 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|